Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus

被引:21
作者
Choe, J-Y [1 ]
Park, S-H [1 ]
Kim, S-K [1 ]
机构
[1] Catholic Univ, Div Rheumatol, Arthrit & Autoimmun Res Ctr, Dept Internal Med,Daegu Sch Med, Taegu 705718, South Korea
关键词
beta; 2-microglobulin; renal involvement; systemic lupus erythematosus; disease activity; SERUM BETA-2-MICROGLOBULIN; BETA(2)-MICROGLOBULIN; NEPHRITIS; BETA2-MICROGLOBULIN; PROTEIN; ACID; MICE;
D O I
10.1177/0961203314547797
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We investigated the association of serum and urine beta 2-microglobulin (beta 2MG) with renal involvement and clinical disease activity in systemic lupus erythematosus (SLE). Methods: Sixty-four female patients with SLE were enrolled. We assessed SLE disease activity (SLEDAI)-2K and measured serum and urine beta 2MG levels, as well as complement (C3 and C4) and anti-dsDNA levels. According to the SLEDAI scores, two groups were categorized: low (0-5 of SLEDAI) and high (6-19 of SLEDAI) disease activity groups. The presence of renal involvement was determined by renal SLEDAI score. Statistical analysis was performed using Spearman's correlation analysis, Mann-Whitney U test, multivariate regression analysis, and logistic regression analysis. Results: Urine beta 2MG levels were significantly different between low and high SLEDAI groups (p = 0.001), but not for serum beta 2MG levels (p = 0.579). Patients with renal involvement showed higher urine beta 2MG levels compared to those without renal involvement (p < 0.001), but again there was not a difference in serum beta 2MG levels (p = 0.228). Urine beta 2MG was closely associated with SLEDAI (r = 0.363, p = 0.003), renal SLEDAI (r = 0.479, p < 0.001), urine protein/Cr (r = 0.416, p = 0.001), and ESR (r = 0.347, p = 0.006), but not serum beta 2MG (r = 0.245, p = 0.051). Urine beta 2MG level was identified as a surrogate for renal involvement (p = 0.009, OR = 1.017, 95% CI 1.004-1.030) and overall disease activity (p = 0.009, OR = 1.020, 95% CI 1.005-1.036). Conclusions: We demonstrated that urine beta 2MG levels are associated with renal involvement and overall clinical disease activity in SLE.
引用
收藏
页码:1486 / 1493
页数:8
相关论文
共 26 条
  • [1] APPEL GB, 1994, ANNU REV MED, V45, P525
  • [2] BETHEA M, 1990, ANN CLIN LAB SCI, V20, P163
  • [3] Cameron JS, 1999, J AM SOC NEPHROL, V10, P413
  • [4] Autoantibody production and cytokine profiles of MHC class I (beta(2)-microglobulin) gene deleted New Zealand Black (NZB) mice
    Chen, SY
    Takeoka, Y
    PikeNobile, L
    Ansari, AA
    Boyd, R
    Gershwin, ME
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (03): : 318 - 327
  • [5] Christianson GJ, 1996, J IMMUNOL, V156, P4932
  • [6] Cook RJ, 2000, J RHEUMATOL, V27, P1892
  • [7] COMPLETE AMINO-ACID SEQUENCE OF BETA2-MICROGLOBULIN
    CUNNINGHAM, BA
    WANG, JL
    BERGGARD, I
    PETERSON, PA
    [J]. BIOCHEMISTRY, 1973, 12 (24) : 4811 - 4822
  • [8] Systemic lupus erythematosus
    D'Cruz, David P.
    Khamashta, Munther A.
    Hughes, Graham R. V.
    [J]. LANCET, 2007, 369 (9561) : 587 - 596
  • [9] SERUM BETA-2-MICROGLOBULIN AS A MARKER OF ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    FONT, J
    COCA, A
    MOLINA, R
    BALLESTA, A
    CARDELLACH, F
    INGELMO, M
    BALAGUE, A
    BALCELLS, A
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1986, 15 (02) : 201 - 205
  • [10] Gladman DD, 2002, J RHEUMATOL, V29, P288